Anaplastic Oligodendroglioma (AO) Completed Phase 1 Trials for RRx-001 (DB12060)
Also known as: Anaplastic Oligodendroglioma / Anaplastic Oligodendrogliomas / Malignant oligodendroglioma / Oligodendroglioma, anaplastic (morphologic abnormality) / Oligodendroglioma malignant
Indication | Status | Phase |
---|---|---|
DBCOND0052374 (Anaplastic Oligodendroglioma (AO)) | Completed | 1 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT02871843 | RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas | Treatment |